Kinaxis Inc, a global leader in integrated supply chain solutions, announced that Zambon , a multinational pharmaceutical company committed to innovating treatments and care to improve the quality of life for patients, has selected Kinaxis to help achieve complete visibility and transparency across its vast global supply chain .
Headquartered in Italy, with 23 subsidiaries, product presence in 87 countries and manufacturing facilities across three continents, the company’s complex supply chain requires a unique approach to balancing supply and demand.
While Zambon remains focused on its three historic therapeutic areas of respiratory disease, urinary tract infections and pain management, the company has expanded its portfolio in recent years by introducing important treatments for Parkinson’s disease, cystic fibrosis and developing a pipeline focused on rare diseases such as bronchiolitis obliterans (BOS) and non-cystic fibrosis bronchiectasis (NCFB). Each requires a manual approach to properly balance production resources and inventory levels based on distinct logistical parameters such as lead times and safety stocks. Kinaxis Maestro™ is the only AI-powered supply chain orchestration platform, enabling pharmaceutical companies to improve sales and operations planning processes and better manage their supply chains, even during periods of demand fluctuations and disruptions.
Also Read: TrueCommerce Partners with Walmart Marketplace for Faster Order Fulfillment
“We are pleased to work with Kinaxis to streamline our supply chain processes and improve visibility across our global operations,” said Andrea Paganelli, head of global industrial business operations at Zambon. “For more than 100 years, our company has been guided by our ongoing commitment and responsibility to care for people’s health. This investment continues our tradition of efficiently delivering critical prescription medications to patients when and where they need them.”
“The pharmaceutical supply chain is incredibly complex, with a dizzying array of stakeholders including manufacturers, distributors, wholesalers, regulators, physicians and pharmacies,” said Fabienne Setre, executive vice president of sales, Europe, Middle East and Africa (EMEA), Kinaxis. “Despite these challenges, savvy industry leaders like Zambon know that a stable future where patients always have access to their medicines is possible, and that with Kinaxis, they can make more informed business decisions while proactively managing the risks of unforeseen disruptions.”
With the addition of Zambon to its customer base, Kinaxis continues to further its footprint in the life sciences industry, providing the branded and generic medicines that countless patients rely on. Managing supply chain complexities in biotechnology, cell and gene therapy, medical devices, over-the-counter drugs and more, Kinaxis customers include some of the world’s leading pharmaceutical companies, including Dr. Reddy’s, Jamieson Wellness, Merck, Novartis, Siemens Hercines and Servier.
SOURCE: Businesswire